What Bhat Bio-Tech does

Bhat Bio-Tech India Private Limited is a privately held, family-controlled diagnostics and biotechnology company incorporated in 1994 in Bangalore, Karnataka. The company designs, develops, manufactures and markets a broad portfolio of in-vitro diagnostic products built on immunochromatographic (rapid), ELISA, hematology, serology and molecular (PCR) platforms, alongside recombinant proteins and reagents, an indigenous DNAmp portable PCR thermal cycler, the in-development i-PCR real-time instrument (results under 20 minutes, patent pending), and the Bhat Gluco-Scan blood glucose monitoring system. It also runs CRO services (custom monoclonal and polyclonal antibody development, cell line and cell culture services, cytotoxicity assays, immunoassay development, microbial barcoding, protein expression and purification) and offers contract manufacturing, third-party labelling and OEM production for unnamed multinational clients.

The business sells across at least four channels: (1) domestic direct field sales through regional/area managers and sales executives in Bangalore, Chennai, Hyderabad, Mumbai, Delhi and Kolkata; (2) Indian channel partners being recruited for Molecular Diagnostics & Instruments, Glucometer and Life Science Products; (3) OTC distribution of home-use products (glucometer strips, pregnancy kits, ovulation kits, urine strips); and (4) international exports spanning over 30 countries across North America, UK, South Asia, Middle East, Central/South America, South Africa and Southeast Asia. Customer segments include hospitals and diagnostic laboratories (primary), biotech and pharmaceutical companies (CRO and OEM), consumers (OTC), environmental and food testing facilities, and educational institutions.

Economically the unit is anchored on three revenue streams (diagnostic product sales, contract research and OEM/manufacturing services, life science product marketing) under a founder/family ownership structure with no disclosed external institutional investors. The 40,000+ sq. ft. integrated R&D, training and manufacturing facility in Bangalore's Electronics City, ISO 9001:2015 / ISO 13485:2016 / CE / GMP certifications, Drugs Controller licensing, and DSIR R&D recognition (2004) collectively form the regulatory and operational backbone of a vertically integrated diagnostics SME.

Name

Bhat Bio-Tech

Legal name

Bhat Bio-Tech India Private Limited

Website

https://bhatbiotech.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

Bhat Bio-Tech India Private Limited designs, develops, manufactures, and markets diagnostic kits (rapid, ELISA, hematology, serology, molecular/PCR), recombinant proteins and a blood glucose monitor, serving hospitals, diagnostic labs, biotech and pharmaceutical clients, and consumers across India and 30+ countries.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Diagnostic test kits
• Molecular diagnostics
• Rapid test kits
• ELISA kits
• Contract research services

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Products Sales: Sale of rapid test kits, ELISA kits, molecular diagnostic kits, instruments, and OTC products including Bhat Gluco-Scan glucometer, urine strips, pregnancy kits, and fertility products.
2. Contract Manufacturing & OEM: Contract manufacturing from add-on jobs to total manufacturing, third-party labelling, and OEM manufacturing of diagnostic products for multinational companies.
3. Contract Research Services: Research services including antibody development, cell line development, protein expression and purification, cytotoxicity assay, immunoassay development, and microbial barcoding services.
4. Life Science Products: Marketing of genomics, proteomics, lab instruments, dehydrated culture media, and recombinant proteins and reagents.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Bhat Bio-Tech designs, develops, manufactures, and markets in-vitro diagnostic products including rapid diagnostic test kits (HIV, Hepatitis, Malaria, Dengue, Chikungunya, Syphilis, pregnancy), ELISA kits, molecular diagnostic kits, hematology and serology reagents, recombinant proteins, and the indigenous DNAmp PCR thermal cycler with i-PCR real-time detection. The company also offers contract manufacturing, OEM/third-party labelling, and contract research services (antibody development, cell line development, protein expression and purification, cytotoxicity assays, immunoassay development). Products are manufactured to ISO 9001, ISO 13485, CE, and GMP standards.

Product overview

Bhat Bio-Tech India Private Limited is a specialized diagnostic and biotechnology company that designs, develops, manufactures, and markets diagnostic products and biotechnology-based products. The company operates with a multi-product portfolio organized around: (1) Rapid Diagnostic Test Kits including HIV, Hepatitis B & C, Malaria, Dengue, Chikungunya, Syphilis, and pregnancy tests; (2) ELISA Test Kits for HIV, Hepatitis B & C detection; (3) Molecular Diagnostic Kits and Instruments including the DNAmp PCR thermal cycler and real-time PCR detection kits; (4) the Bhat Gluco-Scan blood glucose monitoring device; (5) Hematology blood grouping reagents; (6) Serology products including ASO, CRP, RF tests; (7) Recombinant Proteins & Reagents; (8) COVID-19 product line including VTM, RNA extraction kits, rapid tests, and RT-PCR; and (9) Contract Research Services for antibody development, cell culture, and protein expression. The company also offers OEM manufacturing and contract manufacturing services.

Differentiator

Problem solved

Functional benefit

Brands

• BHAT Bio-Scan: Brand for rapid diagnostic test kits including Dengue, Malaria, Syphilis, Chikungunya, Urine parameters, and Ricin tests
• PAREEKSHAK
• AIDSCAN
• HEPA-SCAN
• HEARTSCAN
• OVU-SCAN
• PREGNY-SCAN
• MALERISCAN
• DNAmp
• Bhat Gluco-Scan
• GENEasy

Products and services

• Rapid Diagnostic Test Kits Rapid immunochromatographic and immunoconcentration-based test devices for detection of antibodies and antigens for various diseases including HIV, Hepatitis B & C, Malaria, Dengue, Chikungunya, Syphilis, and pregnancy. Targeted at hospitals, diagnostic laboratories, and blood banks.
• ELISA Test Kits Enzyme-linked immunosorbent assay kits for detection of HIV-1/2, Hepatitis B & C, and other infectious disease markers in serum/plasma with high sensitivity and specificity. Targeted at clinical laboratories and healthcare facilities.
• DNAmp Thermal Cycler (PCR Machine) Indigenous 20-well thermal cycler with 0.2ml tubes, 4.3 inch TFT LCD touch screen display, ultra-portable design weighing 3.4 kg. Targeted at molecular diagnostic laboratories and point-of-care facilities.
• Bhat Gluco-Scan Blood Glucose Monitoring System Blood glucose monitoring system with glucose strips for self-monitoring of blood glucose values by diabetic subjects and physicians. Targeted at consumers (OTC) and healthcare providers.
• Molecular Diagnostic Kits PCR-based fluorescence diagnostic kits for detection of viral and bacterial DNA/RNA including Hepatitis B & C, HIV-1, Chlamydia, HPV, HSV, TB, and other pathogens. Targeted at molecular diagnostic laboratories and healthcare facilities.
• Recombinant Proteins and Reagents Affinity purified recombinant proteins expressed in E. coli with >95% purity as determined by SDS-PAGE, suitable for immunoassay development with minimal batch-to-batch variability. Includes protein expression in bacteria and mammalian cells with His/GST/GFP tags. Targeted at biotechnology and pharmaceutical companies, and research institutions.
• Hematology Products Blood grouping reagents including Anti-A, Anti-B, Anti-AB, Anti-D (IgG/IgM), Anti-H Lectin, Anti-A1 Lectin, and Anti-Human Globulin (Coombs) for blood typing and compatibility testing. Targeted at blood banks and clinical laboratories.
• Serology Products

Quantifiable outcome

• HIV test sensitivity above 99.5% and specificity above 99%
• +4 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Manipal UniversitycoreStrategic or Co-development PartnerPh.D. tie-up program with Manipal University. BBI offers Ph.D. programs in collaboration with Manipal University and applications are invited.
• KIIT UniversityminorStrategic or Co-development PartnerDr. Shama Bhat given guest lecture at The KIIT University, Bhubhaneshwar, Odisha. Represents academic collaboration and knowledge sharing.
• Channel Partners (Generic)coreChannel Partner/ Reseller/ DistributorCompany is actively looking for channel partners for Molecular Diagnostics & Instruments, Glucometer and Life Science Products. No specific named channel partners identified in source material.
• Multinational Companies (Generic)coreOEM/ Whitelabel/ Licensing PartnerContract manufacturing being done for several multinational companies. Products available for OEM include HIV range, Pregnancy range, Hepatitis range, Malaria test kits, and Bio-Chemistry test kits. No specific company names mentioned.

Scale indicators3 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• HiMedia Laboratories: Indian microbiology and molecular biology reagents manufacturer with comparable product lines in dehydrated culture media, recombinant proteins and lab consumables; similar India-based manufacturing and B2B lab-channel GTM.
• J. Mitra & Co. Indian diagnostic kit manufacturer specializing in HIV, Hepatitis, Malaria, Dengue and other infectious-disease rapid and ELISA tests — directly competes with Bhat Bio-Tech in the same Indian hospital and blood-bank channels and exports to similar emerging markets.
• Transasia Bio-Medicals: One of India's largest IVD companies offering biochemistry, hematology, immunology and rapid diagnostic kits across hospital and lab channels — comparable business model with broader scale and similar India-centric manufacturing base.
• Trivitron Healthcare: Indian medical device and IVD company producing diagnostic kits, instruments and reagents with multi-country export footprint — directly comparable scale, product breadth and emerging-market focus.
• Meril Diagnostics: Indian IVD and medtech manufacturer producing rapid diagnostic kits, ELISA, biochemistry analyzers and molecular diagnostics — competing head-to-head with Bhat Bio-Tech in Indian hospital tenders and exports.
• Tulip Diagnostics (now part of Revvity/PerkinElmer): Indian IVD manufacturer with overlapping portfolios in rapid diagnostics, hematology reagents and ELISA kits; comparable Indian manufacturing footprint, CE/ISO certified, and serves both domestic and export markets.

Emerging players

• SD Biosensor: Korean IVD company with strong rapid-test (HIV, Malaria, Dengue) portfolio and rapidly growing India/emerging-market presence — overlapping SKUs with Bhat Bio-Tech's rapid diagnostic range but with deeper commercial infrastructure.

Broad incumbents

• bioMérieux:

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bhat Bio-Tech